Infection control issues after bone marrow transplantation.
Bone marrow transplant recipients are at increased risk of a variety of infections from endogenous and exogenous sources. Various practices, including the use of prophylactic agents and a controlled environment are often employed in the name of infection control. Comparable data are lacking because of non-unified definitions of infection and endpoints. Antibiotic-resistant bacteria and fungi are being isolated more frequently as a result of selective pressure.
Kusne
S
S
Division of Infectious Diseases, Thomas E. Starzl Transplantation Institute, Pittsburgh, Pennsylvania 15213, USA. kusnes2@msx.upmc.edu
Krystofiak
S
S
D000935:Antifungal Agents / Q000627:therapeutic use; D001424:Bacterial Infections / Q000517:prevention & control*; D016026:Bone Marrow Transplantation / Q000009:adverse effects*; D002177:Candidiasis / Q000517:prevention & control; D003428:Cross Infection / Q000517:prevention & control; D006801:Humans; D009181:Mycoses / Q000517:prevention & control*
D000935:Antifungal Agents